84-1110-08 Hypoxia Inducible Factor 1 alpha (Hypoxia Inducible Factor 1 alpha Subunit Basic Helix-loop-helix Transcription Factor, HIF1A, HIF-1 alpha, HIF-1A, HIF1-alpha, ARNT Interacting Protein, Basic Helix-loop-helix PAS Protein MOP1, Member of PAS Protein 1, Member of PAS Superfamily 1, Member of the PAS Superfamily 1, MOP1, PASD8) 100ul H9804-04G
84-1110-08 Hypoxia Inducible Factor 1 alpha (Hypoxia Inducible Factor 1 alpha Subunit Basic Helix-loop-helix Transcription Factor, HIF1A, HIF-1 alpha, HIF-1A, HIF1-alpha, ARNT Interacting Protein, Basic Helix-loop-helix PAS Protein MOP1, Member of PAS Protein 1, Member of PAS Superfamily 1, Member of the PAS Superfamily 1, MOP1, PASD8) 100ul H9804-04G
Hypoxia contributes significantly to the pathophysiology of major categories of human disease, including myocardial and cerebral ischemia, cancer, pulmonary hypertension, congenital heart disease and chronic obstructive pulmonary disease.
HIF-1 is a nuclear protein involved in mammalian oxygen homeostasis.
This occurs as a posttranslational modification by prolyl hydroxylation.
HIF-1 is a heterodimer composed of HIF-1 alpha and HIF-1 beta subunits.
Both subunits are constantly translated.
However, under normoxic conditions, human HIF-1 alpha is hydroxylated at Pro402 or Pro564 by a set of HIF prolyl hydroxylases, is polyubiquinated, and eventually degraded in proteosomes.
Under hypoxic conditions, the lack of hydroxylation prevents HIF degradation and increases transcriptional activity.
Therefore, the concentration of HIF-1 alpha increases in the cell.
In contrast, HIF-1 beta remains stable under either condition.
HIF hydroxylases provide insight into hypoxic cell responses, which may be used to help isolate therapeutic targets.
Applications:Suitable for use in Western Blot.
Other applications not tested.
Recommended Dilution:Optimal dilutions to be determined by the researcher.